Jiven (Triamcinolone Acetonide)

Triamcinolone acetonide binds to intracellular glucocorticoid receptors, forming a complex that moves into the cell nucleus and modifies gene transcription. This reduces the production of inflammatory cytokines, limits immune‑cell activation, and suppresses the overall inflammatory response.

The specific dose of Jiven is determined by the prescribing clinician based on the patient’s condition, severity, and response to therapy. Dosage may vary widely, and the prescriber will set the appropriate regimen.

The safety of triamcinolone acetonide in pregnancy and lactation has not been definitively established. It should only be used if the potential benefit justifies the potential risk to the fetus or infant, and the decision must be made by a qualified healthcare professional.

To place an order, submit an enquiry on the Jiven product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Triamcinolone acetonide is a potent glucocorticoid with a relatively long half‑life, offering strong anti‑inflammatory effects similar to prednisone or methylprednisolone. Choice of agent often depends on physician preference, specific disease indications, and individual patient response or tolerance.

Jiven should be stored at ambient temperature, below 25 °C, in its original packaging. Keep the product away from moisture and direct sunlight to maintain stability.

Jiven is taken orally, usually with a glass of water. The exact dosing schedule—such as once daily or divided doses—will be prescribed by the treating physician based on the therapeutic indication.

Serious risks include adrenal insufficiency if the drug is stopped abruptly, severe infections due to immunosuppression, osteoporosis with long‑term use, cataracts or glaucoma, and rare psychiatric effects such as psychosis. Patients should be monitored closely for these complications.

Jiven is contraindicated in patients with systemic fungal infections, known hypersensitivity to triamcinolone or any component of the formulation, and in individuals receiving live vaccines. Caution is also advised for patients with uncontrolled diabetes, severe hypertension, or active peptic ulcer disease.